Sofia D. Merajver

Sofia D. Merajver is a Professor at the University of Michigan in both the Department of Internal Medicine and Epidemiology. She directs the UM Breast and Ovarian Cancer Risk Evaluation Program and serves as Scientific Director of the UM Rogel Cancer Center's Breast Oncology Program.

• Education:
  • MD from University of Michigan (1987)
  • PhD in Physics from University of Maryland (1978)
  • Residency in Internal Medicine at UM Medical Center (1988-1991)
  • Fellowship in Hematology/Oncology at UM (1991-1993)

Her research focuses on:

• Molecular genetics of aggressive breast cancer subtypes
• Global health disparities in breast cancer outcomes
• Metabolic vulnerabilities in triple-negative breast cancer (TNBC)
• Integration of clinical, social, and environmental factors in cancer risk

Recent publications highlight advances in:

• Precision medicine platforms for lung and breast cancers
• Metabolic pathway targeting (e.g., malic enzyme inhibitors)
• Genetic variant reclassification in diverse populations

She leads global initiatives to strengthen cancer programs in:

• Egypt, Tunisia, Morocco
• Ghana, Sub-Saharan Africa
• Ecuador, Germany